Form 4: J.H. Whitney Sells AVAH Shares in Secondary Offering

J.H. Whitney Equity Partners VII, a 10% owner and director of Aveanna Healthcare Holdings, Inc., reported the sale of over 1.25 million shares of common stock.

Summary

• J.H. Whitney Equity Partners VII, LLC, a 10% owner and director of Aveanna Healthcare Holdings, Inc. (AVAH), reported a transaction involving the sale of common stock.
• On October 24, 2025, J.H. Whitney VII, L.P., an affiliate of the reporting person, sold 1,251,909 shares of Aveanna Healthcare Holdings, Inc. common stock.
• The shares were disposed of at a price of $9 per share.
• This transaction was executed pursuant to an option to purchase additional shares in an underwritten secondary offering.
• Following this transaction, J.H. Whitney Equity Partners VII, LLC, through its affiliated entities, indirectly beneficially owns 19,292,787 shares via J.H. Whitney VII, L.P., 15,523,809 shares via PSA Healthcare Investment Holdings LLC, and 1,426,034 shares via PSA Iliad Holdings LLC.

Sentiment

Score: 4

Explanation: The sentiment is mildly negative to neutral. While the sale by a 10% owner could be perceived negatively, it was part of a pre-planned secondary offering, which mitigates some of the negative implications of an unplanned insider sale. It represents a reduction in a significant institutional holding.

Negatives

• A significant sale of 1,251,909 shares by a 10% owner and director could potentially exert downward pressure on the stock price due to increased supply.
• The reduction in holding by a major institutional investor, even if planned, might be interpreted by some market participants as a decrease in conviction regarding the company's future prospects.

Future Outlook

NA

Industry Context

This transaction represents a significant sale by a major institutional investor in the healthcare services sector. While the filing itself doesn't provide broader industry context, such sales can be part of portfolio rebalancing or a strategic exit, which might be influenced by the investor's outlook on the sector or specific company performance relative to peers.

Related Party Transactions

• J.H. Whitney Equity Partners VII, LLC, as a 10% owner and director, is considered a related party to Aveanna Healthcare Holdings, Inc.
• The sale of 1,251,909 shares by J.H. Whitney VII, L.P., an affiliate of J.H. Whitney Equity Partners VII, LLC, constitutes a related party transaction.

Stakeholder Impact

• Shareholders: The sale of a significant block of shares by a major investor could lead to increased supply in the market, potentially impacting share price. Existing shareholders might view this as a signal, though the 'secondary offering' context suggests a planned event.
• Company (Aveanna Healthcare Holdings, Inc.): The company itself does not directly receive proceeds from a secondary offering by an existing shareholder. However, increased liquidity in its stock could be a long-term benefit.

Key Dates

Recommendation

The filing reports a significant sale by a 10% owner and director, J.H. Whitney Equity Partners VII, LLC, through an affiliate. While the sale of over 1.25 million shares at $9 each is substantial, it was executed as part of a pre-planned underwritten secondary offering. This context suggests a strategic portfolio adjustment rather than a sudden loss of confidence. Investors should monitor the stock for any short-term price volatility due to the increased supply but should not necessarily interpret this as a fundamental negative signal for the company's long-term prospects without further information. Therefore, a 'hold' recommendation is appropriate, advising investors to maintain their current position while observing further developments.

Keywords

Aveanna Healthcare Holdings, AVAH, J.H. Whitney Equity Partners, SEC Form 4, Insider Transaction, Stock Sale, Secondary Offering, 10% Owner, Director Transaction